ZA973071B - Novel peptides suitable for use in antigen specific immuno-suppressive therapy - Google Patents

Novel peptides suitable for use in antigen specific immuno-suppressive therapy

Info

Publication number
ZA973071B
ZA973071B ZA973071A ZA973071A ZA973071B ZA 973071 B ZA973071 B ZA 973071B ZA 973071 A ZA973071 A ZA 973071A ZA 973071 A ZA973071 A ZA 973071A ZA 973071 B ZA973071 B ZA 973071B
Authority
ZA
South Africa
Prior art keywords
antigen specific
novel peptides
peptides suitable
suppressive therapy
specific immuno
Prior art date
Application number
ZA973071A
Other languages
English (en)
Inventor
Anna Maria Helena Boots
Gijsbertus Francisc Verheijden
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of ZA973071B publication Critical patent/ZA973071B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA973071A 1996-04-24 1997-04-10 Novel peptides suitable for use in antigen specific immuno-suppressive therapy ZA973071B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96201106 1996-04-24

Publications (1)

Publication Number Publication Date
ZA973071B true ZA973071B (en) 1998-08-05

Family

ID=8223915

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA973071A ZA973071B (en) 1996-04-24 1997-04-10 Novel peptides suitable for use in antigen specific immuno-suppressive therapy

Country Status (20)

Country Link
US (1) US6184204B1 (cs)
EP (1) EP0920451A1 (cs)
JP (1) JP2000510106A (cs)
KR (1) KR20000010561A (cs)
CN (1) CN1216551A (cs)
AR (1) AR006813A1 (cs)
AU (1) AU719481B2 (cs)
BR (1) BR9708744A (cs)
CA (1) CA2251680A1 (cs)
CZ (1) CZ340698A3 (cs)
HU (1) HUP9901375A3 (cs)
IL (1) IL120561A0 (cs)
NO (1) NO984937L (cs)
NZ (1) NZ332427A (cs)
PL (1) PL329618A1 (cs)
RU (1) RU2199548C2 (cs)
TR (1) TR199802135T2 (cs)
TW (1) TW575583B (cs)
WO (1) WO1997040068A1 (cs)
ZA (1) ZA973071B (cs)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9912378A (pt) * 1998-07-23 2001-04-17 Akzo Nobel Nv Peptìdeo, composição farmacêutica, uso de um ou mais dos peptìdeos, e, composição para diagnóstico.
CA2386398A1 (en) * 1999-10-18 2001-04-26 Akzo Nobel Nv Modified peptides and peptidomimetics for use in immunotherapy
IL132611A0 (en) * 1999-10-27 2001-03-19 Yeda Res & Dev Synthetic genes and polypeptides and pharmaceutical compositions comprising them
EP1309591B1 (en) 2000-08-14 2007-01-24 Ortho-McNeil Pharmaceutical, Inc. Substituted pyrazoles
US7002985B2 (en) * 2001-01-16 2006-02-21 Motorola, Inc. Method and apparatus for organizing and scheduling multimedia data transfers over a wireless channel
MXPA04009228A (es) * 2002-03-22 2005-08-16 Gpc Biotech Ag Compuestos inmunosupresores, metodos y usos relacionados con los mismos.
CU23504A1 (es) * 2004-09-24 2010-04-13 Ct Ingenieria Genetica Biotech Péptidos y derivados tipo apl de la hsp60 y composiciones farmacéuticas
ES2534752T3 (es) * 2004-12-07 2015-04-27 Toray Industries, Inc. Nuevo péptido antigénico contra el cáncer y utilización del mismo
PL1856153T3 (pl) * 2005-02-28 2011-06-30 Bio Y As Przeciwciała monoklonalne YKL-40
FR2908654B1 (fr) 2006-11-20 2014-04-04 Oreal Utilisation cosmetique de proteines de type chitinase
RU2374841C1 (ru) * 2008-04-22 2009-12-10 Государственное научное учреждение Всероссийский научно-исследовательский и технологический институт птицеводства Способ индукции иммунологической толерантности у птиц
RS53782B1 (sr) * 2008-10-01 2015-06-30 Immatics Biotechnologies Gmbh Preparati tumor-asociranih peptida i odgovarajuća antikancerska vakcina za tretman glioblastoma (gbm) i drugih kancera
RU2008140688A (ru) * 2008-10-15 2010-04-20 Михаил Аркадьевич Шурдов (RU) Иммуносупрессивный пептид
CA2768246A1 (en) 2009-06-11 2010-12-16 The University Of Guelph Serine rich peptides having antioxidative stress properties
CA2779161A1 (en) 2009-10-28 2011-05-05 University Of Manitoba Yellow pea seed protein-derived peptides
JP6153467B2 (ja) 2010-05-31 2017-06-28 ロンドン ヘルス サイエンシーズ センター リサーチ インコーポレイテッドＬｏｎｄｏｎ Ｈｅａｌｔｈ Ｓｃｉｅｎｃｅｓ Ｃｅｎｔｒｅ Ｒｅｓｅａｒｃｈ Ｉｎｃ． Ｒｈａｍｍ結合ペプチド
EP3565596A4 (en) 2017-01-05 2020-12-16 Brown University PROCESSES AND COMPOSITIONS RELATING TO ANTI-CHI3LI ANTIBODY REAGENTS
US10766968B2 (en) 2017-08-23 2020-09-08 Brown University Methods and compositions relating to anti-CHI3L1 antibody reagents to treat cancer
CN115260296B (zh) * 2022-06-30 2026-04-28 中国人民解放军空军军医大学 基于自身免疫病特异性多肽、特异性抗体及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2007422C1 (ru) * 1991-06-21 1994-02-15 Российский государственный медицинский университет Способ получения плацентарного протеина
FR2697845B1 (fr) * 1992-11-12 1995-02-17 Inst Nat Sante Rech Med Séquences peptidiques du récepteur EBV/C3d, applications diagnostiques et thérapeutiques.
RU2048816C1 (ru) * 1993-07-06 1995-11-27 Закрытое акционерное общество "Симера" Биологически активный препарат "лимфокинин", обладающий иммуномодулирующими свойствами
CA2164498C (en) * 1993-07-09 2007-09-11 Paul A. Price Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices
CA2183157A1 (en) * 1994-02-16 1995-08-24 Naoshi Kamada Immunosuppressive compounds and method of preparing same
IL115744A (en) 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39

Also Published As

Publication number Publication date
BR9708744A (pt) 1999-08-03
WO1997040068A1 (en) 1997-10-30
JP2000510106A (ja) 2000-08-08
EP0920451A1 (en) 1999-06-09
AU719481B2 (en) 2000-05-11
AU2768597A (en) 1997-11-12
RU2199548C2 (ru) 2003-02-27
HUP9901375A3 (en) 2000-10-30
CA2251680A1 (en) 1997-10-30
TR199802135T2 (xx) 1999-01-18
IL120561A0 (en) 1997-07-13
NO984937L (no) 1998-12-01
NZ332427A (en) 2000-03-27
PL329618A1 (en) 1999-03-29
US6184204B1 (en) 2001-02-06
HUP9901375A2 (hu) 1999-08-30
AR006813A1 (es) 1999-09-29
KR20000010561A (ko) 2000-02-15
CN1216551A (zh) 1999-05-12
TW575583B (en) 2004-02-11
CZ340698A3 (cs) 1999-02-17
NO984937D0 (no) 1998-10-23

Similar Documents

Publication Publication Date Title
HUP9904177A3 (en) Antibody against human parathormone related peptides
ZA973071B (en) Novel peptides suitable for use in antigen specific immuno-suppressive therapy
PL322589A1 (en) Radiotracer-labelled peptides for use in diagnostics and therapy
GB9609641D0 (en) Compounds useful in therapy
GB9601724D0 (en) Therapeutic agents
PL338920A1 (en) Therapeutic agents
GB9600235D0 (en) Therapeutic agents
GB2321191B (en) Peptides for use in wound treatment
GB9516293D0 (en) Novel peptides and their use as vaccines
GB9419021D0 (en) Therapeutic protein
GB9626446D0 (en) Therapeutic device
ZA96240B (en) Novel peptides their preparation and use
ZA96239B (en) Novel peptides their preparation and use
GB9604400D0 (en) Compounds useful in therapy
GB9512896D0 (en) Peptides for use in vaccines
ZA977005B (en) Therapeutic uses
GB9613705D0 (en) Novel peptides
GB9615658D0 (en) Therapeutic agents
ZA944483B (en) Peptides for use in medicine
TW310631U (en) Improved medicine grinder
GB9422293D0 (en) Therapeutic protein
GB9605465D0 (en) Therapeutic use
GB9620880D0 (en) Therapeutic use
GB9605523D0 (en) Therapeutic use
GB9504627D0 (en) Compounds for use in therapy